Zai Lab Ltd (NASDAQ:ZLAB)
| 153.16 Delayed Data As of May 14 |  +1.28 / +0.84%Today’s Change | 62.89 Today|||52-Week Range 193.54 | +13.17% Year-to-Date |
Latest ZLAB News | Press Releases
No recent news for Zai Lab Ltd.
Today’s Trading
| Previous close | 151.88 |
| Today’s open | 149.60 |
| Day’s range | 149.58 - 154.36 |
| Volume | 9,789 |
| Average volume (3 months) | 492,832 |
| Market cap | $14.5B |
Data as of 3:59pm ET, 05/14/2021
Growth & Valuation
| Earnings growth (last year) | -55.85% |
| Earnings growth (this year) | -39.58% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +277.03% |
| P/E ratio | NM |
| Price/Sales | 214.34 |
| Price/Book | 11.47 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BMRNBiomarin Pharmaceuti... | +1.48 | +1.96% |
| TECHBio-Techne Corp | +2.99 | +0.75% |
| EXASExact Sciences Corp | +3.25 | +3.47% |
| NVAXNovavax Inc | +10.05 | +8.31% |
Data as of 4:03pm ET, 05/14/2021
Financials
| Next reporting date | September 2, 2021 |
| EPS forecast (this quarter) | -$1.32 |
| Annual revenue (last year) | $49.0M |
| Annual profit (last year) | -$269.4M |
| Net profit margin | -549.26% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Shanghai, Shanghai |
Forecasts
